Cargando…
Improving the Yield of Xenocoumacin 1 Enabled by In Situ Product Removal
[Image: see text] Xenocoumacin 1 (Xcn1), a major antimicrobial compound produced by Xenorhabdus nematophila CB6, has great potential to be developed into a novel biofungicide. However, its low yield in the producing cells has limited its possible commercial applications. In this study, we explored t...
Autores principales: | Dong, Yijie, Li, Xiaohui, Duan, Jiaqi, Qin, Youcai, Yang, Xiufen, Ren, Jie, Li, Guangyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439382/ https://www.ncbi.nlm.nih.gov/pubmed/32832792 http://dx.doi.org/10.1021/acsomega.0c02357 |
Ejemplares similares
-
Regulation of antimicrobial activity and xenocoumacins biosynthesis by pH in Xenorhabdus nematophila
por: Guo, Shuqi, et al.
Publicado: (2017) -
CpxR negatively regulates the production of xenocoumacin 1, a dihydroisocoumarin derivative produced by Xenorhabdus nematophila
por: Zhang, Shujing, et al.
Publicado: (2018) -
Xenorhabdus khoisanae SB10 produces Lys-rich PAX lipopeptides and a Xenocoumacin in its antimicrobial complex
por: Dreyer, J., et al.
Publicado: (2019) -
Isolation and Characterization of Two New Deoxynivalenol-Degrading Strains, Bacillus sp. HN117 and Bacillus sp. N22
por: Li, Beibei, et al.
Publicado: (2022) -
Hrip1 mediates rice cell wall fortification and phytoalexins elicitation to confer immunity against Magnaporthe oryzae
por: Ninkuu, Vincent, et al.
Publicado: (2022)